Assessment of alemtuzumab third dose for resumed MS activity; two North-East England centres experience
Year: 2024
Type: conference-paper
Study design: Observational Study
Authors: Eissa Alyaa Hassan Ali, Duddy Martin, Petheram Kate
Institutions: Royal Victoria Infirmary, Sunderland Royal Hospital
Language: English
Subfield: Pathology and Forensic Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W4404183225
